This preclinical study demonstrates that exacerbating impaired insulin signaling with STZ in diet-induced obesity models does not worsen cardiac or somatosensory dysfunction, providing insights for translational mouse models.
Does not support STZ worsening cardiac dysfunction in obese models; leaves open translational validity for diabetes complication studies.
in the dorsal root ganglia. These discoveries enhance our understanding of metabolic activity, insulin resistance, neuropathy, and cardiac dysfunction of diet-induced models of obesity and diabetes. The exacerbation of impaired insulin signaling pathways by STZ did not lead to or worsen cardiac and somatosensory dysfunction. Additionally, they offer valuable insights into suitable diet induced translational mouse models, thereby advancing the development of potential interventions for associated conditions.
No takes yet. Share an insight, caveat, or question.
Elshareif et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: